FEBRILE NEUTROPENIA EPISODES AND EVALUATION OF AVAILABLE BIOMARKERS AMONG CHILDREN WITH HEMATOLOGICAL MALIGNANCIES

被引：0
|
作者：
Kourti, M. [1 ]
Iosifidis, I. [2 ]
Slavakis, A. [3 ]
Sidi, V. [1 ]
Geladari, A. [2 ]
Goumberi, S. [1 ,4 ]
Koliouskas, D. [1 ]
Roilides, E. [5 ]
机构：
[1] Hippokrateion Hosp, Dept Pediat Oncol, Thessaloniki, Greece
[2] Hippokrateion Hosp, Pediat Infect Dis Unit, Thessaloniki, Greece
[3] Hippokrateion Hosp, Dept Biochem, Thessaloniki, Greece
[4] Hippokrateion Hosp, Thessaloniki, Greece
[5] Aristotle Univ Thessaloniki, Pediat Infect Dis Unit, Thessaloniki, Greece
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
B1875
引用
收藏
页码：723 / 723
页数：1
相关论文
共 50 条
  • [1] FEBRILE NEUTROPENIA AND AVAILABLE BIOMARKERS AMONG CHILDREN WITH HEMATOLOGICAL MALIGNANCIES
    Garcia-Espinoza, A.
    Figueroa-Carbajal, J.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 234 - 235
  • [2] FEBRILE NEUTROPENIA AND AVAILABLE BIOMARKERS AMONG CHILDREN WITH HEMATOLOGICAL MALIGNANCIES
    Kourti, M.
    Iosifidis, I.
    Slavakis, A.
    Geladari, A.
    Goumberi, S.
    Roilides, E.
    Koliouskas, D.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 234 - 234
  • [3] The Evaluation of Nasal Cultures in Patients with Hematological Malignancies During Febrile Neutropenic Episodes
    Ulug, Mehmet
    Ayaz, Celal
    Celen, Mustafa Kemal
    HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, 2012, 50 (04): : 136 - 141
  • [4] Evaluation of risk prediction criteria for episodes of febrile neutropenia in children with cancer
    Alexander, SW
    Wade, KC
    Hibberd, PL
    Parsons, SK
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2002, 24 (01) : 38 - 42
  • [5] Evaluation of Thrombin Generation in the Early Stages of Sepsis in Patients with Hematological Malignancies and Febrile Neutropenia
    Picoli-Quaino, Susan K.
    Alves, Brunna E.
    Aranha, Francisco J. P.
    Lorand-Metze, Irene
    De Souza, Carmino Antonio
    Annichino-Bizzacchi, Joyce M.
    De Paula, Erich V.
    BLOOD, 2011, 118 (21) : 1436 - 1437
  • [6] GARENOXACIN PROPHYLAXIS FOR FEBRILE NEUTROPENIA AFTER CHEMOTHERAPY IN HEMATOLOGICAL MALIGNANCIES
    Nakamura, N.
    Tsurumi, H.
    Shibata, Y.
    Mabuchi, R.
    Kitagawa, J.
    Suetsugu, A.
    Kanemura, N.
    Goto, N.
    Hara, T.
    Moriwaki, H.
    ANNALS OF ONCOLOGY, 2013, 24 : 47 - 47
  • [7] Efficacy and safety of micafungin for treating febrile neutropenia in hematological malignancies
    Goto, Naoe
    Hara, Takeshi
    Tsurumi, Hisashi
    Ogawa, Kengo
    Kitagawa, Junichi
    Kanemura, Nobuhiro
    Kasahara, Senji
    Yamada, Toshiki
    Shimizu, Masahito
    Nakamura, Mitsuhiro
    Matsuura, Katsuhiko
    Moriwaki, Hisataka
    AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (11) : 872 - 876
  • [8] Mortality in patients with hematological malignancies, febrile neutropenia, and septic shock
    Islas-Munoz, Beda
    Volkow-Fernandez, Patricia
    Silva-Zamora, Jorge
    Ramirez-Ibarguen, Ana
    Cornejo-Juarez, Patricia
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2024, 18 (02): : 235 - 242
  • [9] MANAGEMENT OF FEBRILE NEUTROPENIA EPISODES IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES BY USING THE MULTINATIONAL ASSOCIATION FOR SUPPORTIVE CARE IN CANCER RISK INDEX
    Argyrou, A.
    Pergaminou, M.
    Galanopoulos, A.
    Marinakis, T.
    Michalis, E.
    Gkortzolidis, G.
    Anagnostopoulos, N. I.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 186 - 187
  • [10] FEBRILE EPISODES IN CHILDREN AT RISK OF NEUTROPENIA: LOOKING FOR A FOCUS
    Ross, Emma Louise
    Pollock, Louisa
    Kennedy, Helen
    Williams, Craig
    Sastry, Jairam
    PEDIATRIC BLOOD & CANCER, 2011, 57 (05) : 846 - 846
12345